These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Quantitative sensory testing for neuropathic pain and its relevance for physiotherapy]. Adler M, Taxer B. Schmerz; 2022 Dec; 36(6):437-446. PubMed ID: 34424391 [Abstract] [Full Text] [Related]
27. Spinal cord stimulation reduces mechanical hyperalgesia and glial cell activation in animals with neuropathic pain. Sato KL, Johanek LM, Sanada LS, Sluka KA. Anesth Analg; 2014 Feb; 118(2):464-472. PubMed ID: 24361846 [Abstract] [Full Text] [Related]
28. Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities. Backonja MM, Walk D, Edwards RR, Sehgal N, Moeller-Bertram T, Wasan A, Irving G, Argoff C, Wallace M. Clin J Pain; 2009 Sep; 25(7):641-7. PubMed ID: 19692807 [Abstract] [Full Text] [Related]
29. Network model of nociceptive processing in the superficial spinal dorsal horn reveals mechanisms of hyperalgesia, allodynia, and spinal cord stimulation. Gilbert JE, Zhang T, Esteller R, Grill WM. J Neurophysiol; 2023 Nov 01; 130(5):1103-1117. PubMed ID: 37727912 [Abstract] [Full Text] [Related]
36. Quantitative Sensory Testing of Spinal Cord and Dorsal Root Ganglion Stimulation in Chronic Pain Patients. Sankarasubramanian V, Chiravuri S, Mirzakhalili E, Anaya CJ, Scott JR, Brummett CM, Clauw DJ, Patil PG, Harte SE, Lempka SF. Neuromodulation; 2021 Jun 01; 24(4):672-684. PubMed ID: 33471409 [Abstract] [Full Text] [Related]
37. Efficacy of different spinal cord stimulation paradigms for the treatment of chronic neuropathic pain (PARS-trial): study protocol for a double-blinded, randomized, and placebo-controlled crossover trial. Ahmadi R, Campos B, Hajiabadi MM, Doerr-Harim C, Tenckhoff S, Rasche D, Unterberg A, Vesper J, Bruckner T, Tronnier V. Trials; 2021 Jan 25; 22(1):87. PubMed ID: 33494781 [Abstract] [Full Text] [Related]
38. Changes in quantitative sensory testing and patient perspectives following spinal cord stimulation for persistent spinal pain syndrome: An observational study with long-term follow-up. Plantaz YJGM, van Dongen RTM, Witkam RL, Vissers KCP, Timmerman H. Eur J Pain; 2022 Aug 25; 26(7):1581-1593. PubMed ID: 35638567 [Abstract] [Full Text] [Related]
39. Endocannabinoid activation of CB1 receptors contributes to long-lasting reversal of neuropathic pain by repetitive spinal cord stimulation. Sun L, Tai L, Qiu Q, Mitchell R, Fleetwood-Walker S, Joosten EA, Cheung CW. Eur J Pain; 2017 May 25; 21(5):804-814. PubMed ID: 28107590 [Abstract] [Full Text] [Related]
40. Dynamic Pain Phenotypes are Associated with Spinal Cord Stimulation-Induced Reduction in Pain: A Repeated Measures Observational Pilot Study. Campbell CM, Buenaver LF, Raja SN, Kiley KB, Swedberg LJ, Wacnik PW, Cohen SP, Erdek MA, Williams KA, Christo PJ. Pain Med; 2015 Jul 25; 16(7):1349-60. PubMed ID: 25800088 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]